Shattuck Labs, Inc. – NASDAQ:STTK
Founder-led company
Shattuck Labs stock price today
$1.01
-0.22
-18.55%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 19 minutes
Shattuck Labs stock price monthly change
-70.41%
month
Shattuck Labs stock price quarterly change
-70.41%
quarter
Shattuck Labs stock price yearly change
-81.52%
year
Shattuck Labs key metrics
Market Cap | 54.18M |
Enterprise value | 87.34M |
P/E | -1.27 |
EV/Sales | 133.97 |
EV/EBITDA | -0.85 |
Price/Sales | 200.19 |
Price/Book | 0.74 |
PEG ratio | 0.01 |
EPS | -1.93 |
Revenue | 2.71M |
EBITDA | -86.33M |
Income | -85.07M |
Revenue Q/Q | 1856.14% |
Revenue Y/Y | 282.93% |
Profit margin | -15635.74% |
Oper. margin | -15848.01% |
Gross margin | 7.67% |
EBIT margin | -15848.01% |
EBITDA margin | -3180.04% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeShattuck Labs stock price history
Shattuck Labs stock forecast
Shattuck Labs financial statements
| Jun 2023 | 200K | -21.34M | -10673% |
|---|---|---|---|
| Sep 2023 | 686K | -27.54M | -4014.72% |
| Dec 2023 | 714K | -17.68M | -2477.17% |
| Mar 2024 | 1.11M | -18.50M | -1659.55% |
| Mar 2024 | 1.11M | -18.50M | -1659.55% |
|---|---|---|---|
| Sep 2025 | 1.06M | -18.92M | -1777.18% |
| Oct 2025 | 1.57M | -20.22M | -1287.78% |
| Dec 2025 | 1.66M | -20.22M | -1216.3% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 155270000 | 16.81M | 10.83% |
|---|---|---|---|
| Sep 2023 | 130457000 | 17.67M | 13.55% |
| Dec 2023 | 159564000 | 14.85M | 9.31% |
| Mar 2024 | 146335000 | 17.52M | 11.97% |
| Jun 2023 | -18.61M | 24.43M | 33K |
|---|---|---|---|
| Sep 2023 | -16.73M | -14.55M | 21K |
| Dec 2023 | -19.41M | 55.85M | 48.56M |
| Mar 2024 | -16.16M | -33.27M | -184K |
Shattuck Labs alternative data
| Aug 2023 | 105 |
|---|---|
| Sep 2023 | 105 |
| Oct 2023 | 105 |
| Nov 2023 | 105 |
| Dec 2023 | 105 |
| Jan 2024 | 105 |
| Feb 2024 | 105 |
| Mar 2024 | 75 |
| Apr 2024 | 75 |
| May 2024 | 75 |
| Jun 2024 | 75 |
| Jul 2024 | 75 |
Shattuck Labs other data
44.94%
-5.63%
of STTK is owned by hedge funds
19.04M
-2.37M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jan 2024 | 0 | 25000 |
| Mar 2024 | 0 | 11354 |
| Jun 2024 | 22816 | 0 |
| Oct 2024 | 36500 | 0 |
| Dec 2024 | 133371 | 133371 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | REDMILE GROUP, LLC director, 10 percent owner: | Common Stock, par value $0.0001 per share | 133,371 | $1.25 | $166,714 | ||
Sale | REDMILE GROUP, LLC director, 10 percent owner: | Common Stock, par value $0.0001 per share | 133,371 | $1.25 | $166,714 | ||
Purchase | SCHREIBER TAYLOR director, officer.. | Common Stock | 36,500 | $1.21 | $44,238 | ||
Purchase | BROUS TYLER director | Common Stock | 3,000 | $3.9 | $11,700 | ||
Purchase | BROUS TYLER director | Common Stock | 5,416 | $3.89 | $21,068 | ||
Purchase | SCHREIBER TAYLOR director, officer.. | Common Stock | 14,400 | $3.47 | $50,011 | ||
Option | SCHREIBER TAYLOR director, officer.. | Stock Option (Right to Buy) | 3,050 | $3.57 | $10,889 | ||
Option | SCHREIBER TAYLOR director, officer.. | Common Stock | 3,050 | $3.57 | $10,889 | ||
Option | STOUT STEPHEN officer: See Remarks | Common Stock | 6,459 | $3.57 | $23,059 | ||
Option | STOUT STEPHEN officer: See Remarks | Common Stock | 4,650 | $3.51 | $16,321 |
| Patent |
|---|
Application Filling date: 22 Jun 2020 Issue date: 18 Aug 2022 |
Application Filling date: 6 Apr 2022 Issue date: 21 Jul 2022 |
Application Filling date: 27 Feb 2020 Issue date: 16 Jun 2022 |
Application Filling date: 28 Jan 2022 Issue date: 12 May 2022 |
Application Filling date: 1 Nov 2021 Issue date: 21 Apr 2022 |
Grant Utility: CSF1R-based chimeric proteins Filling date: 6 Nov 2019 Issue date: 8 Mar 2022 |
Grant Utility: CSF1R-CD40L chimeric proteins Filling date: 27 Feb 2018 Issue date: 8 Mar 2022 |
Application Filling date: 16 Jul 2021 Issue date: 27 Jan 2022 |
Application Filling date: 29 Aug 2019 Issue date: 9 Dec 2021 |
Grant Utility: VSIG8-based chimeric proteins Filling date: 28 Oct 2019 Issue date: 7 Dec 2021 |
| Quarter | Transcript |
|---|---|
| Q3 2023 10 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q4 2022 26 Feb 2023 | Q4 2022 Earnings Call Transcript |
| Q3 2022 12 Nov 2022 | Q3 2022 Earnings Call Transcript |
| Q2 2021 14 Aug 2021 | Q2 2021 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Dr. Arundathy Nirmalini Pandite M.B.A., M.D. (1959) Chief Medical Officer | $583,000 |
| Dr. Taylor H. Schreiber M.D., Ph.D. (1980) Co-Founder, Chief Executive Officer & Director | $526,110 |
| Ms. Casi DeYoung (1971) Chief Bus. Officer | $440,660 |
-
What's the price of Shattuck Labs stock today?
One share of Shattuck Labs stock can currently be purchased for approximately $1.01.
-
When is Shattuck Labs's next earnings date?
Unfortunately, Shattuck Labs's (STTK) next earnings date is currently unknown.
-
Does Shattuck Labs pay dividends?
No, Shattuck Labs does not pay dividends.
-
How much money does Shattuck Labs make?
Shattuck Labs has a market capitalization of 54.18M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 154.14% to 1.66M US dollars.
-
What is Shattuck Labs's stock symbol?
Shattuck Labs, Inc. is traded on the NASDAQ under the ticker symbol "STTK".
-
What is Shattuck Labs's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Shattuck Labs?
Shares of Shattuck Labs can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Shattuck Labs's key executives?
Shattuck Labs's management team includes the following people:
- Dr. Arundathy Nirmalini Pandite M.B.A., M.D. Chief Medical Officer(age: 66, pay: $583,000)
- Dr. Taylor H. Schreiber M.D., Ph.D. Co-Founder, Chief Executive Officer & Director(age: 45, pay: $526,110)
- Ms. Casi DeYoung Chief Bus. Officer(age: 54, pay: $440,660)
-
Is Shattuck Labs founder-led company?
Yes, Shattuck Labs is a company led by its founder Dr. Taylor H. Schreiber M.D., Ph.D..
-
How many employees does Shattuck Labs have?
As Jul 2024, Shattuck Labs employs 75 workers.
-
When Shattuck Labs went public?
Shattuck Labs, Inc. is publicly traded company for more then 4 years since IPO on 9 Oct 2020.
-
What is Shattuck Labs's official website?
The official website for Shattuck Labs is shattucklabs.com.
-
Where are Shattuck Labs's headquarters?
Shattuck Labs is headquartered at 500 West 5th Street, Austin, TX.
-
How can i contact Shattuck Labs?
Shattuck Labs's mailing address is 500 West 5th Street, Austin, TX and company can be reached via phone at +51 29004690.
Shattuck Labs company profile:
Shattuck Labs, Inc.
shattucklabs.comExchange:
NASDAQ
Full time employees:
75
Industry:
Biotechnology
Sector:
Healthcare
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorporated in 2016 and is headquartered in Austin, Texas.
500 West 5th Street
Austin, TX 78703
Austin, TX 78703
CIK: 0001680367
ISIN: US82024L1035
CUSIP: 82024L103
